Skip to main content

Showing 1 match for the following: Inventor: "Hartman, Zach" ×

CD47/SIRPα checkpoint blockade in combination with HER2 antibody for the treatment of HER2-positive breast cancer

CD47/SIRPα checkpoint blockade in combination with HER2 antibody for the treatment of HER2-positive breast cancer

Value Proposition Approximately 20% of breast cancers overexpress the human epidermal growth factor receptor type 2 (HER2), which is recognized as an oncogenic driver of an aggressive cancer phenotype with a poor prognosis. The clinical…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us